For Immediate Release
October 5, 2023
Cranford, NJ– On Friday, October 6, Steve Brozak, Managing Partner and President of WBB Securities will moderate a panel discussion titled: “Infectious Disease: From Neglect to Respect Made Possible by New Technologies” at the BioFuture forum in New York City.
Panelists include biotech executives, physicians, and the former head of BARDA, Dr. Rick Bright. The discussion will address the critical importance of new approaches to infectious diseases, and the importance of a changed response to the emergence of new bacterial, viral, and fungal pathogens, including diagnostics.
Registration for either in-person or virtual access to this and other presentations can be accessed at BioFuture 2023 Registration
About WBB Securities.
WBB Securities is a leading Investment Management, Investment Banking, and Equity Research firm focused primarily on the life sciences niche. Established in 2001 with offices in New Jersey, New York, and California. WBB Securities is registered with the SEC as a broker-dealer and is a member of FINRA, as well as a state-registered investment advisor with a proprietary trading desk. The firm is comprised of a nationwide team of respected senior investment and research professionals serving institutional and high-net-worth clients.
About BioFuture.
BioFuture is where relentless pioneers, innovators, and entrepreneurs gather to assess the present and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s inaugural summit, They will explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
